Insight Brief
July 06, 2016

Lab of the Future

How the lab of the future provides scientific, technological, and operational expertise to improve outcomes
Today’s drug development pipeline includes many new and exciting opportunities – from precision medicine approaches to complex targeted therapies, compounds and drug-specific companion diagnostics. To improve the probability of success for this pipeline, collaborative teams with a wide range of expertise are required. The days when a single biopharmaceutical company might develop an oncology drug from preclinical research through market delivery are simply not as common as they once were.

Download this insight brief to read how Q2 Solutions' CEO Costa Panagos sees the “lab of the future” as one that can provide scientific, technological, and operational expertise to better meet the needs of patients, sites, and the sponsors they support.

Costa Panagos, CEO

Related Services:
Translating Data into Insights with Bioinformatics

Delivery Excellence

Optimizing the customer experience through innovative solutions implemented with premium service that accelerates drug development outcomes

Read More